BRPI0916972A2 - gerador de estrôncio-82/rubídio-82, método para produzir um agente diagnóstico compreendendo rubídio-82, o referido agente diagnóstico e seu uso em medicina - Google Patents

gerador de estrôncio-82/rubídio-82, método para produzir um agente diagnóstico compreendendo rubídio-82, o referido agente diagnóstico e seu uso em medicina

Info

Publication number
BRPI0916972A2
BRPI0916972A2 BRPI0916972A BRPI0916972A BRPI0916972A2 BR PI0916972 A2 BRPI0916972 A2 BR PI0916972A2 BR PI0916972 A BRPI0916972 A BR PI0916972A BR PI0916972 A BRPI0916972 A BR PI0916972A BR PI0916972 A2 BRPI0916972 A2 BR PI0916972A2
Authority
BR
Brazil
Prior art keywords
rubidium
diagnostic agent
strontium
generator
producing
Prior art date
Application number
BRPI0916972A
Other languages
English (en)
Inventor
Roland Anthonius Maria Johannes Claessens
Original Assignee
Stichting Jeroen Bosch Ziekenhuis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Jeroen Bosch Ziekenhuis filed Critical Stichting Jeroen Bosch Ziekenhuis
Publication of BRPI0916972A2 publication Critical patent/BRPI0916972A2/pt
Publication of BRPI0916972B1 publication Critical patent/BRPI0916972B1/pt
Publication of BRPI0916972B8 publication Critical patent/BRPI0916972B8/pt

Links

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0031—Rubidium

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Insulating Materials (AREA)
BRPI0916972A 2008-08-18 2009-08-14 gerador de estrôncio-82/rubídio-82, método para produzir um agente diagnóstico compreendendo rubídio-82, o referido agente diagnóstico e seu uso em medicina BRPI0916972B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08075710A EP2157583B1 (en) 2008-08-18 2008-08-18 Strontium-82/rubidium-82 generator, method for producing a rubidium-82 comprising diagnostic agent, said diagnostic agent and its use in medicine
EP08075710.7 2008-08-18
PCT/EP2009/060584 WO2010020596A1 (en) 2008-08-18 2009-08-14 Strontium-82/rubidium-82 generator, method for producing a rubidium-82 comprising diagnostic agent, said diagnostic agent and its use in medicine

Publications (3)

Publication Number Publication Date
BRPI0916972A2 true BRPI0916972A2 (pt) 2016-07-26
BRPI0916972B1 BRPI0916972B1 (pt) 2020-12-15
BRPI0916972B8 BRPI0916972B8 (pt) 2021-07-27

Family

ID=40547891

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916972A BRPI0916972B8 (pt) 2008-08-18 2009-08-14 gerador de estrôncio-82/rubídio-82, método para produzir um agente diagnóstico compreendendo rubídio-82, o referido agente diagnóstico e seu uso em medicina

Country Status (17)

Country Link
US (1) US9023305B2 (pt)
EP (1) EP2157583B1 (pt)
AT (1) ATE515041T1 (pt)
AU (1) AU2009284211B2 (pt)
BR (1) BRPI0916972B8 (pt)
CA (1) CA2733674C (pt)
CY (1) CY1112091T1 (pt)
DK (1) DK2157583T3 (pt)
ES (1) ES2368662T3 (pt)
HR (1) HRP20110547T1 (pt)
IL (1) IL211264A (pt)
PL (1) PL2157583T3 (pt)
PT (1) PT2157583E (pt)
RU (1) RU2507618C2 (pt)
SI (1) SI2157583T1 (pt)
WO (1) WO2010020596A1 (pt)
ZA (1) ZA201100710B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597053B2 (en) 2008-06-11 2017-03-21 Bracco Diagnostics Inc. Infusion systems including computer-facilitated maintenance and/or operation and methods of use
KR101932426B1 (ko) 2008-06-11 2019-03-20 브라코 다이어그노스틱스 아이엔씨. 주입시스템을 위한 차폐조립체
US7862534B2 (en) 2008-06-11 2011-01-04 Bracco Diagnostics Inc. Infusion circuit subassemblies
US8708352B2 (en) 2008-06-11 2014-04-29 Bracco Diagnostics Inc. Cabinet structure configurations for infusion systems
US8317674B2 (en) 2008-06-11 2012-11-27 Bracco Diagnostics Inc. Shielding assemblies for infusion systems
US8216181B2 (en) 2008-11-19 2012-07-10 Bracco Diagnostics, Inc. Apparatus and methods for support of a membrane filter in a medical infusion system
GB201112051D0 (en) * 2011-07-13 2011-08-31 Mallinckrodt Llc Process
ES2985370T3 (es) * 2011-11-10 2024-11-05 Hoffmann La Roche Sistema de cromatografía en columna preparativa
ES2959671T3 (es) * 2012-09-05 2024-02-27 Jubilant Draximage Inc Control del sistema de elución de rubidio
FR2995536B1 (fr) * 2012-09-17 2014-09-26 Lemer Prot Anti X Par Abreviation Soc Lemer Pax Unite medicale pour l'injection de rubidium 82 a un patient
CA2940697C (en) 2014-03-13 2023-02-21 Bracco Diagnostics Inc. Real time nuclear isotope detection
US11752254B2 (en) 2016-09-20 2023-09-12 Bracco Diagnostics Inc. Radioisotope delivery system with multiple detectors to detect gamma and beta emissions
KR102733368B1 (ko) * 2018-03-28 2024-11-21 브라코 다이어그노스틱스 아이엔씨. 방사성 동위 원소 생성기의 종료 수명의 조기 검출
ES2924376T3 (es) 2018-03-28 2022-10-06 Bracco Diagnostics Inc Conjunto de blindaje para un sistema de administración de radioisótopos que tiene múltiples detectores de radiación
WO2021168272A1 (en) 2020-02-21 2021-08-26 Bracco Diagnostics Inc. Radioisotope generator early breakthrough detection
US20210265069A1 (en) * 2020-02-24 2021-08-26 Jubilant Draximage Inc. Heat resistant generator columns for elution systems
US11443866B2 (en) * 2020-02-24 2022-09-13 Jubilant Draximage Inc. Generator columns for elution systems loaded with pre-charged matrix
RU2765983C1 (ru) * 2021-03-30 2022-02-07 Федеральное государственное бюджетное учреждение науки Институт ядерных исследований Российской академии наук (ИЯИ РАН) Способ изготовления и повышения производительности медицинского генератора стронций-82/рубидий-82
RU2767769C1 (ru) * 2021-09-17 2022-03-21 Общество с ограниченной ответственностью Научно-производственная фирма ПОЗИТОМ-ПРО (ООО НПФ "Позитом-ПРО") Стронций-82/рубидий-82 генератор и способ его приготовления

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406877A (en) * 1980-06-04 1983-09-27 E. R. Squibb & Sons, Inc. 82 Rb Generating method and eluent
EP0650739B1 (en) * 1993-10-28 2003-02-26 Medrad, Inc. Total system for contrast delivery
US5966583A (en) * 1998-05-12 1999-10-12 The Regents Of The University Of California Recovery of strontium activity from a strontium-82/rubidium-82 generator
US7476377B2 (en) * 2001-08-02 2009-01-13 Lynntech, Inc. Rubidium-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets
US7023000B2 (en) * 2003-05-21 2006-04-04 Triumf Isotope generator
US8071959B2 (en) * 2005-12-21 2011-12-06 Ottawa Heart Institute Research Corp. Rubidium generator for cardiac perfusion imaging and method of making and maintaining same
RU2467692C1 (ru) * 2011-06-30 2012-11-27 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГУ "РНЦРХТ" Минздравсоцразвития России) Инфузионная система для радиофармпрепаратов на основе рубидия-82 из генератора

Also Published As

Publication number Publication date
CA2733674C (en) 2017-03-21
PT2157583E (pt) 2011-08-25
PL2157583T3 (pl) 2011-11-30
ZA201100710B (en) 2012-05-01
HRP20110547T1 (hr) 2011-09-30
US20110182808A1 (en) 2011-07-28
US9023305B2 (en) 2015-05-05
EP2157583A1 (en) 2010-02-24
CA2733674A1 (en) 2010-02-25
CY1112091T1 (el) 2015-11-04
WO2010020596A1 (en) 2010-02-25
BRPI0916972B8 (pt) 2021-07-27
BRPI0916972B1 (pt) 2020-12-15
DK2157583T3 (da) 2011-10-24
RU2011110262A (ru) 2012-09-27
IL211264A0 (en) 2011-04-28
EP2157583B1 (en) 2011-06-29
SI2157583T1 (sl) 2011-10-28
RU2507618C2 (ru) 2014-02-20
ES2368662T3 (es) 2011-11-21
ATE515041T1 (de) 2011-07-15
AU2009284211A1 (en) 2010-02-25
AU2009284211B2 (en) 2014-09-11
IL211264A (en) 2016-05-31

Similar Documents

Publication Publication Date Title
BRPI0916972B8 (pt) gerador de estrôncio-82/rubídio-82, método para produzir um agente diagnóstico compreendendo rubídio-82, o referido agente diagnóstico e seu uso em medicina
Chen et al. Modern methods for delivery of drugs across the blood–brain barrier
AP3022A (en) Self-powered pump for heated liquid, fluid heatingand storage tank and fluid heating system employi ng same
BR112015022195A8 (pt) sistema e método de diálise peritoneal, instalação para proporcionar trocas de diálise peritoneal, e instalação walk-in
BRPI0817811A2 (pt) Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas.
BRPI0719141A2 (pt) Sistema e método para gerar imagem de câncer de próstata, meio legível por computador, e, usos do sistema e de tomografia óptica difusa
BRPI0919701A2 (pt) Formulação de proteção de planta aquosa líquida, uso de uma formulação de proteção aquosa, método para tratar semete, e para controlar organismos nocivos á planta.
BR112014026990A2 (pt) anticorpo , ácido nucleico , vetores , célula hospedeira , composição farmacêutica , uso de um anticorpo e método para o tratamento de um paciente com necessidade de terapia.
MX365513B (es) Forma de dosificacion de dispersion rapida que contiene levetiracetam.
BR112013026260A2 (pt) dispositivos e métodos para terapia de formatação em ablação aperfeiçoada com fluido
WO2008082561A3 (en) Mixtures of ammonia and ionic liquids
BR112013014522A2 (pt) anticorpo anti-cd20 afucosilado e seu uso, composição e método para tratamento de um paciente que sofre de câncer
BRPI0917768A2 (pt) dispositivo médico para uso em cirurgia extracorpória
DK2510085T3 (da) Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom
CL2013001250A1 (es) Composicion intravenosa que contiene ibuprofeno y paracetamol combinados en dosis definidas; y uso en el tratamiento del dolor y/o inflamacion.
CL2014000704A1 (es) Canilla mezcladora con filtro que comprende un cuerpo, una entrada de agua caliente y otra de agua corriente, una columna tubular con un primer cabezal que lleva un pico radial de servicio, un cartucho de filtro en el interior de la columna y un registro de filtrado.
BRPI0707190A2 (pt) método para a produção de partìculas, partìcula, agente de contraste, composição terapêutica, e, composição de partìcula
EA201490325A1 (ru) Теплообменник с ламинаризатором
WO2010057491A3 (de) Vorrichtung zum mechanischen erwärmen von flüssigkeiten
IT1393373B1 (it) Dispositivo perforatore, particolarmente per sacche di contenimento di fluidi fisiologici ad uso medicale e simili.
DE502008001641D1 (de) Druckwellentherapievorrichtung mit integrierter Röntgenanlage
CL2013003536A1 (es) Compuestos derivados de 4-fenil indazol y 4-fenil-ciclopentapirazol, inhibidores de aldosterona sintasa; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades del riñon, tales como enfermedad renal cronica y nefropatia diabetica.
CL2007002362A1 (es) Forma de cristal de la epotilona b; composicion farmaceutica que la comprende; y uso para el tratamiento de una enfermedad proliferativa, tal como un tumor.
Wohlfarth Viscosity of the mixture (1) N, N-dimethylformamide;(2) N, N-dimethylacetamide: Data extract from Landolt-Börnstein IV/25: Viscosity of Pure Organic Liquids and Binary Liquid Mixtures
Behnam Far et al. Medicine and Sanitary-Remedial Methods in Old Iranian Texts

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: STICHTING JEROEN BOSCH ZIEKENHUIS (NL)

B25A Requested transfer of rights approved

Owner name: RUBIGEN B.V. (NL)

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: G21G 4/08

Ipc: A61K 51/12 (1995.01), G21G 1/00 (1968.09)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09Y Publication of grant cancelled [chapter 9.1.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.1 NA RPI NO 2532 DE 16/07/2019 POR TER SIDO INDEVIDA.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/08/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO